Protagonist Therapeutics ... (PTGX)
NASDAQ: PTGX
· Real-Time Price · USD
56.04
1.05 (1.91%)
At close: Aug 15, 2025, 3:59 PM
56.07
0.05%
After-hours: Aug 15, 2025, 04:34 PM EDT
Protagonist Therapeutics Balance Sheet Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Cash & Equivalents | 168.54M | 139.65M | 97.25M | 131.12M | 355.64M | 172.57M | 186.73M | 230.53M | 235.38M | 127.69M | 125.74M | 152.82M | 120.24M | 98.48M | 123.67M | 120.54M | 192.41M | 83M |
Short-Term Investments | 401.92M | 434.71M | 321.66M | 337.6M | 208.35M | 150.07M | 154.89M | 90.22M | 78.02M | 103.07M | 111.61M | 114.62M | 171.65M | 206.81M | 203.24M | 193.76M | 161.87M | 190.48M |
Long-Term Investments | n/a | 123.52M | 140.25M | 114.56M | 31.67M | 225K | 225K | 1.99M | 225K | 225K | 225K | 225K | 225K | 225K | 225K | 38.17M | 26.12M | 6.25M |
Other Long-Term Assets | 102.78M | 225K | 2.33M | 225K | n/a | n/a | 225K | 225K | n/a | n/a | 5.72M | n/a | n/a | n/a | n/a | 225K | 225K | 225K |
Receivables | n/a | 27.09M | 168.49M | 2.67M | 1.37M | 300.4M | 10.33M | 65K | 50K | 51K | 52K | 620K | 3.36M | 28.5M | 1.57M | 4.51M | 9.86M | n/a |
Inventory | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -2.05M | -50K | -51K | -94K | -620K | n/a | 7.73M | 8.5M | n/a | n/a | n/a |
Other Current Assets | 32.06M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 3.35M | n/a | n/a | n/a | 1.92M |
Total Current Assets | 602.53M | 605.86M | 591.64M | 476.77M | 570.92M | 627.55M | 355.58M | 324.88M | 316.94M | 235.74M | 237.35M | 276.62M | 304.3M | 341.52M | 340.74M | 327.69M | 371.82M | 285.51M |
Property-Plant & Equipment | 12.7M | 12.53M | 12.61M | 12.3M | 12.03M | 1.5M | 2.15M | 2.92M | 3.3M | 3.9M | 4.63M | 5.33M | 5.99M | 6.55M | 6.73M | 7.09M | 6.07M | 6.08M |
Goodwill & Intangibles | n/a | n/a | n/a | n/a | n/a | n/a | -446K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Total Long-Term Assets | 115.48M | 136.27M | 153.08M | 127.09M | 43.7M | 1.72M | 2.37M | 5.13M | 3.52M | 4.12M | 10.57M | 5.56M | 6.21M | 6.77M | 6.96M | 45.49M | 32.41M | 12.56M |
Total Assets | 718.01M | 742.13M | 744.73M | 603.86M | 614.63M | 629.28M | 357.95M | 330.02M | 320.47M | 239.86M | 247.93M | 282.17M | 310.51M | 348.3M | 347.69M | 373.18M | 404.23M | 298.07M |
Account Payables | 3.25M | 2.92M | 1.61M | 3.05M | 3.63M | 3.51M | 772K | 1.25M | 4.57M | 4.02M | 3.64M | 4.71M | 1.41M | 7.16M | 1.6M | 706K | 7.91M | 2.73M |
Deferred Revenue | 14.69M | 16.89M | 18.89M | 19.7M | 20.12M | 16.13M | 3K | 3K | 10K | 22K | 69K | 32K | 80K | 1.15M | 1.6M | 3.36M | 13.4M | 12.59M |
Short-Term Debt | 2.17M | n/a | n/a | n/a | n/a | n/a | 1.14M | 1.8M | 2.45M | 2.6M | n/a | 2.43M | 2.35M | 2.27M | n/a | 2.03M | 1.57M | 1.51M |
Other Current Liabilities | 15.4M | 2.9M | 11.08M | 20.62M | 9.73M | 19.49M | 11.34M | 18.34M | 13.3M | 11.93M | 484K | 22.24M | 29.32M | 28.18M | 2.91M | 27.43M | 26.14M | 21.22M |
Total Current Liabilities | 35.51M | 35.11M | 47.4M | 44.58M | 41.58M | 39.91M | 21.27M | 27.87M | 26.4M | 23.23M | 31.18M | 36.75M | 40.09M | 43.46M | 44.02M | 39.16M | 42.97M | 34.52M |
Long-Term Debt | 9.11M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Long-Term Liabilities | 5.38M | 8.18M | 11.68M | 16.51M | n/a | n/a | -221K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 121K | 121K | 121K |
Total Long-Term Liabilities | 14.48M | 17.97M | 22.03M | 27.36M | 31.73M | 28.92M | 221K | n/a | n/a | 462K | 784.68M | 1.8M | 2.45M | 3.06M | 3.66M | 4.36M | 3.81M | 4.22M |
Total Liabilities | 49.99M | 53.08M | 69.43M | 71.94M | 73.31M | 68.83M | 21.27M | 27.87M | 26.4M | 23.69M | 784.68M | 38.56M | 42.53M | 46.52M | 47.67M | 43.52M | 46.78M | 38.74M |
Total Debt | 11.28M | 11.36M | 10.87M | 10.9M | 10.97M | 462K | 1.14M | 1.8M | 2.45M | 3.06M | 3.66M | 4.24M | 4.8M | 5.34M | 5.86M | 6.26M | 5.26M | 5.61M |
Common Stock | 1K | 1K | 1K | 1K | 1K | 1K | 1K | 1K | 1K | 1K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Retained Earnings | -386.95M | -352.18M | -340.52M | -472.2M | -438.99M | -408.37M | -615.71M | -643.04M | -608.94M | -570.48M | -536.75M | -502.56M | -471.33M | -430.29M | -409.36M | -372.45M | -338.65M | -307.81M |
Comprehensive Income | -15K | 85K | -82K | 1.34M | -249K | -229K | -105K | -170K | -198K | -122K | -359K | -480K | -720K | -472K | -299K | -204K | -59K | -33K |
Shareholders Equity | 668.02M | 689.05M | 675.29M | 531.91M | 541.32M | 560.44M | 336.68M | -643.04M | 294.07M | -570.48M | -536.75M | 243.62M | 267.98M | 301.78M | -409.36M | 329.66M | 357.45M | 259.33M |
Total Investments | n/a | 558.22M | 461.92M | 452.16M | 240.03M | 150.29M | 154.89M | 90.22M | 78.02M | 103.07M | 111.61M | 114.62M | 171.65M | 206.81M | 203.24M | 231.93M | 187.99M | 196.73M |